Hepatitis B virus infection.
Lee
W M
WM
Department of Internal Medicine, University of Texas Southwestern Medical School, Dallas 75235-9151, USA.
D000328:Adult; D000998:Antiviral Agents / Q000627:therapeutic use; D016679:Genome, Viral; D006509:Hepatitis B / Q000150:complications / Q000453:epidemiology / Q000276:immunology / Q000628:therapy; D006510:Hepatitis B Antibodies; D006511:Hepatitis B Antigens; D017325:Hepatitis B Vaccines; D006515:Hepatitis B virus / Q000235:genetics / Q000276:immunology / Q000502:physiology; D006801:Humans; D007231:Infant, Newborn; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use; D008099:Liver / Q000473:pathology; D011994:Recombinant Proteins
D000998:Antiviral Agents; D006510:Hepatitis B Antibodies; D006511:Hepatitis B Antigens; D017325:Hepatitis B Vaccines; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins